Drug Preclinical Safety Evaluation 药物临床前安全评价 Drug Safety Oversight Board 药品安全监督委员会 ; 药品安全监管部 ; 新的药品安全监管部 Office of Drug Safety 药品安全办公室...
基于12个网页-相关网页
The biomarkers of myocardial injury are used widely in clinical diagnosis of heart diseases. However, application of the biomarker in drug preclinical safety evaluation is relatively less.
心肌损伤生物标志物的检测在心脏疾病临床诊断上被广泛应用，但是在新药的非临床安全评价方面，心肌损伤标志物的应用相对滞后。
Study inspection of preclinical safety evaluation of drug is an important responsibility for quality assurance unit (QAU) with good laboratory practice (GLP).
对新药安全性实验实施质量监督检查是药物非临床研究质量管理规范(GLP)赋予质量保证部门(QAU)的重要职责。
应用推荐